Alvotech
ALVONASDAQHealthcareDrug Manufacturers - Specialty & Generic
As of Oct 15, 2026 close
- Market cap
- $1.59B
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $2.94$9.05
- Volume (live)
- -
- Avg. volume (3M)
- 1.18M
Alvotech (ALVO) Stock Price & Financial Analysis
Alvotech Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $4.95 - $5.30 |
|---|---|
| 52-Week High | $9.05 |
| 52-Week Low | $2.94 |
| Open | $5.27 |
| Volume (last close) | 1.06M |
| Average Volume (3M) | 1.18M |
| Revenue (TTM) | 491.95M |
|---|---|
| Net Income (TTM) | -179.59M |
| Free Cash Flow (TTM) | -317.15M |
| EPS (TTM) | −$0.56 |
| Profit Margin | -36.51% |
| Operating Margin | 9.65% |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Market Cap | 1.59B |
|---|---|
| Shares Outstanding | 299.16M |
| Price to Sales (P/S) | 3.23 |
| Price to Book (P/B) | -8.30 |
| EV/EBITDA | 18.14 |
| 50-Day MA | $5.08 |
|---|---|
| 200-Day MA | $4.21 |
| 1-Year Change | −39.31% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Alvotech at a Glance
As of the Oct 16, 2026 close, Alvotech (ALVO) has a market capitalization of $1.59B. The stock trades at 3.2× sales. Over the trailing twelve months it lost $179.59M on revenue of $491.95M and burned $317.15M of free cash flow. Revenue fell 12.1% year over year.
As of its latest reported balance sheet, it holds $142.75M in cash and securities against $1.31B of debt, a net debt position of $1.16B.
Alvotech does not currently pay a dividend.
The share price is down 39.3% over the past year. At $5.00 (the Oct 16, 2026 close) it sits within its 52-week range of $2.94 to $9.04, above its 200-day moving average of $4.21.
Based on 2 professional analyst ratings from the past 90 days, the consensus is Buy.
Frequently Asked Questions About Alvotech
What is the current stock price for ALVO?
As of the Oct 16, 2026 close, ALVO stock trades at $5.00. The 52-week range is $2.94–$9.05, with a day range of $4.95–$5.30.
What is the P/E ratio for ALVO?
The P/E ratio (Price-to-Earnings) for ALVO is shown in the Key Statistics section. This valuation metric helps compare Alvotech to industry peers.
Does ALVO pay dividends?
Alvotech does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for ALVO?
Based on ratings from 2 professional analysts over the last 90 days, the consensus for ALVO is Buy.
What is the market cap of ALVO?
As of the Oct 16, 2026 close, Alvotech's market capitalization is $1.50B, classifying it as a small-cap company. Alvotech operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.